CClinicalTrials.gg
CompletedNCT01341626Updated Mar 11, 2022

Juvenile Justice Girls Randomized Control Trial: Young Adult Follow-up

An interventional study of Treatment Foster Care (TFCO) and Group Care in Delinquency and Drug Use, sponsored by Oregon Social Learning Center. Completed at 2 sites in United States. Open to female participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2022-03-11.

Sponsored by Oregon Social Learning Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
166
Allocation
Randomized
Ages
13 Years to 18 Years
Sex
Female
01

Study summary

This study is a young adult follow-up of 166 females who originally participated in an RCT during adolescence due to their involvement in the juvenile justice system.

Read the detailed description

Females under age 18 years old are the fastest-growing segment of the juvenile justice population and are at risk for negative co-occurring outcomes including drug abuse, HIV/STI risk, criminal behavior, and educational failure. As they enter young adulthood, this constellation of behaviors puts them at heightened risk for early parenthood and subsequent involvement in the child welfare system (for their parenting behaviors) and the adult corrections system (for criminal behaviors). Such system involvement is costly, and its prevention would be of great significance to public health; however, very little is known about factors leading to females' success/failure in young adulthood and factors that might prevent involvement in these two public systems. This study aims to further our understanding of the pathways to and the prevention of HIV/STI risk, drug use, and child welfare and adult corrections involvement by following-up 166 women who participated in two randomized intervention trials aimed at reducing delinquency during adolescence. In the original studies, juvenile justice girls who had been referred for out-of-home placement due to chronic delinquency were randomly assigned to services as usual or to Treatment Foster Care Oregon (TFCO, formerly known as MTFC). Efficacy of the intervention with this sample has been shown at 12- and 24-month follow-ups on criminal referral rates, days spent in locked settings, deviant peer associations, educational engagement, and pregnancy prevention. The investigators propose to examine the developmental pathways for these juvenile justice girls into young adulthood (ages 21-28 years) using innovative data collection and data analytic techniques, with foci on the long-term effects of TFCO, the mediators of young adult adjustment and child welfare/corrections involvement, and the cost effectiveness and cost avoidance of TFCO on these outcomes. The overarching aim is to identify potential targets for subsequent intervention. One in-person assessment is proposed with each female and her current romantic partner (if she has one); in addition, telephone interviews will be conducted every 6 months for the duration of the study, and system data from child welfare and adult corrections will be collected.

02

Conditions studied

  • Delinquency
  • Drug Use

Keywords

  • delinquency
  • drug use
  • HIV risk behavior
  • economic costs
03

In context

Lead sponsor

Oregon Social Learning Center is the lead sponsor of 19 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • female
  • 13-17 years old
  • at least one criminal referral in the prior year
  • court-mandated placement in out-of-home care

Exclusion criteria

Exclusion Criteria:

  • Currently pregnant
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
166 participants (actual)

Study arms

  • Experimental
    Treatment Foster Care Oregon (TFCO)

    Youth are placed individually in well-trained and supervised foster homes. Basic components include: (a) daily telephone contact with TFCO parents using the Parent Daily Report; (b) weekly foster parent group meetings focused on supervision, training in parenting practices, and support; (c) an individualized behavior management program implemented daily in the home by foster parent; (d) individualized skills training for the youth; (e) family therapy for aftercare family focused on parent management strategies; (f) close monitoring of school attendance, performance, and homework completion; (g) case management to coordinate TFCO, family, peer, and school settings; (h) 24-hour on-call staff availability to TFCO and biological parents; and (i) psychiatric consultation.

    Behavioral: Treatment Foster Care (TFCO)

  • Active comparator
    Group Care

    Group Care is the usual service for youth placed in out-of-home care for chronic delinquency in Oregon. These programs represented typical services for girls being referred to out-of-home care by the juvenile justice system and had 2-51 youth in residence (M = 21) and 1-50 staff members (Mdn = 2); most also had onsite schooling. Although the programs differed somewhat in theoretical orientations, 86% reported that they endorsed a specific treatment model, of which the primary philosophy was a behavioral (70%), eclectic (26%), or family-style therapeutic approach (4%).

    Behavioral: Group Care

Interventions

  • BehavioralTreatment Foster Care (TFCO)

    Youth placed individually in well-trained and supervised foster homes. Basic components: (a) daily telephone contact with TFCO parents; (b) weekly foster parent group meetings focused on supervision, training in parenting practices, and support; (c) an individualized behavior management program implemented daily in the home by foster parent; (d) individualized skills training for the youth; (e) family therapy for aftercare family focused on parent management strategies; (f) close monitoring of school attendance, performance, and homework completion; (g) case management to coordinate TFCO, family, peer, and school settings; (h) 24-hour on-call staff availability to TFCO and biological parents; and (i) psychiatric consultation. Services typically last approximately 6 months.

    Also known as: Multidimensional Treatment Foster Care

  • BehavioralGroup Care

    Group Care is the usual service for youth placed in out-of-home care for chronic delinquency in Oregon. These programs represented typical services for girls being referred to out-of-home care by the juvenile justice system and had 2-51 youth in residence (M = 21) and 1-50 staff members (Mdn = 2); most also had onsite schooling. Although the programs differed somewhat in theoretical orientations, 86% reported that they endorsed a specific treatment model, of which the primary philosophy was a behavioral (70%), eclectic (26%), or family-style therapeutic approach (4%). Services typically last approximately 6 months.

06

What researchers measure

Primary outcomes

  1. Delinquency

    Measured as self-reported criminal activity and count of official arrests and criminal referrals

    Time frame: Months 12, 24, 36, and young adulthood (ave. of 7 year follow-up + 10 year follow-up)

  2. substance use

    Measured via self-reported use and diagnostic interview assessment

    Time frame: Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up + 10 year follow-up)

Secondary outcomes

  1. HIV risk behavior

    Measured as self-reported engagement in sexual behaviors

    Time frame: Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up)

  2. economic costs

    Measured by comparing the costs of intervention delivery relative to the two intervention programs relative to costs incurred through time in detention, jail, and prison; relative to costs incurred due to child welfare involvement; and relative to symptom counts on self-report inventories.

    Time frame: young adulthood (age 18-28; average of 7-year follow-up)

  3. Depression

    Measured on the CESD depression inventory and the Brief Symptom Inventory, and via diagnostic interview

    Time frame: Months 6, 12, 18, 24 and Young Adult (average 7 year follow-up)

07

Study locations

2 sites
  • Oregon Social Learning Center
    Eugene, Oregon 97401, United States
  • University of Oregon
    Eugene, Oregon 97403, United States
08

References and documents

Publications

  • Harold GT, Kerr DC, Van Ryzin M, DeGarmo DS, Rhoades KA, Leve LD. Depressive symptom trajectories among girls in the juvenile justice system: 24-month outcomes of an RCT of Multidimensional Treatment Foster Care. Prev Sci. 2013 Oct;14(5):437-46. doi: 10.1007/s11121-012-0317-y. PubMed 23417664 ↗
  • Van Ryzin MJ, Leve LD. Affiliation with delinquent peers as a mediator of the effects of multidimensional treatment foster care for delinquent girls. J Consult Clin Psychol. 2012 Aug;80(4):588-96. doi: 10.1037/a0027336. Epub 2012 Feb 20. PubMed 22352857 ↗
  • Kerr DC, Leve LD, Chamberlain P. Pregnancy rates among juvenile justice girls in two randomized controlled trials of multidimensional treatment foster care. J Consult Clin Psychol. 2009 Jun;77(3):588-93. doi: 10.1037/a0015289. PubMed 19485598 ↗
  • Chamberlain P, Leve LD, Degarmo DS. Multidimensional treatment foster care for girls in the juvenile justice system: 2-year follow-up of a randomized clinical trial. J Consult Clin Psychol. 2007 Feb;75(1):187-93. doi: 10.1037/0022-006X.75.1.187. PubMed 17295579 ↗
  • Leve LD, Chamberlain P, Reid JB. Intervention outcomes for girls referred from juvenile justice: effects on delinquency. J Consult Clin Psychol. 2005 Dec;73(6):1181-5. doi: 10.1037/0022-006X.73.6.1181. PubMed 16392991 ↗
  • Level LD, Chamberlain P. Association with delinquent peers: intervention effects for youth in the juvenile justice system. J Abnorm Child Psychol. 2005 Jun;33(3):339-47. doi: 10.1007/s10802-005-3571-7. PubMed 15957561 ↗
  • Leve LD, Chamberlain P. A Randomized Evaluation of Multidimensional Treatment Foster Care: Effects on School Attendance and Homework Completion in Juvenile Justice Girls. Res Soc Work Pract. 2007 Nov 1;17(6):657-663. doi: 10.1177/1049731506293971. PubMed 18159224 ↗
  • Rhoades KA, Chamberlain P, Roberts R, Leve LD. MTFC for High Risk Adolescent Girls: A Comparison of Outcomes in England and the United States. J Child Adolesc Subst Abuse. 2013 Nov 1;22(5):435-449. doi: 10.1080/1067828X.2013.788887. PubMed 24003300 ↗
  • Leve LD, Kerr DC, Harold GT. Young Adult Outcomes Associated with Teen Pregnancy Among High-Risk Girls in an RCT of Multidimensional Treatment Foster Care. J Child Adolesc Subst Abuse. 2013 Sep 1;22(5):421-434. doi: 10.1080/1067828X.2013.788886. PubMed 24453470 ↗
  • Poulton R, Van Ryzin MJ, Harold GT, Chamberlain P, Fowler D, Cannon M, Arseneault L, Leve LD. Effects of multidimensional treatment foster care on psychotic symptoms in girls. J Am Acad Child Adolesc Psychiatry. 2014 Dec;53(12):1279-87. doi: 10.1016/j.jaac.2014.08.014. Epub 2014 Sep 16. PubMed 25457926 ↗
  • Kerr DC, DeGarmo DS, Leve LD, Chamberlain P. Juvenile justice girls' depressive symptoms and suicidal ideation 9 years after Multidimensional Treatment Foster Care. J Consult Clin Psychol. 2014 Aug;82(4):684-93. doi: 10.1037/a0036521. Epub 2014 Apr 14. PubMed 24731234 ↗
  • Rhoades KA, Leve LD, Harold GT, Kim H, Chamberlain P. Drug Use Trajectories After a Randomized Controlled Trial of MTFC: Associations with Partner Drug Use. J Res Adolesc. 2014 Mar 1;24(1):40-54. doi: 10.1111/jora.12077. PubMed 24729667 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01341626
Lead sponsor
Oregon Social Learning Center
Collaborators
National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), University of Oregon
Responsible party
Leslie D. Leve (Study Principal Investigator, University of Oregon) — Principal investigator
First posted
Apr 26, 2011
Start date
Jan 1997
Primary completion
Dec 2016
Completion
Dec 2016
Last update
Mar 11, 2022

Study contacts

Leslie Leve, PhD
principal investigator · University of Oregon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion